Duchenne Muscular Dystrophy - Practical Neurology
Duchenne clinical trial offers promising results using unique therapy
Promising gene therapy for Duchenne muscular dystrophy
Viltolarsen & Duchenne Muscular dystrophy | CPAA
Ongoing clinical trials 1 and approval status of therapeutic approaches... | Download Table
New muscular dystrophy treatment shows promise in pre-clinical trials
ICH GCP - The study of EN001 in patients with Duchenne muscular dystrophy - ICH GCP
Duchenne Muscular Dystrophy (DMD): Clinical Trial OF Systemic Delivery Of Micro-Dystrophin Gene Therapy In Children With DMD Shows Positive Results - Thailand Medical News
Clinical Trials » Powell Center for Rare Disease Research and Therapy » College of Medicine » University of Florida
Status of therapeutic development in Duchenne muscular dystrophy. | Download Scientific Diagram
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug - ScienceDirect
Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020
Vamorolone demonstrates efficacy, safety for boys with Duchenne muscular dystrophy
Duchenne Muscular Dystrophy » Powell Center for Rare Disease Research and Therapy » College of Medicine » University of Florida
Clinical Trials | FSHD Society
Duchenne Muscular Dystrophy - Capricor
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) - Neuromuscular Disorders
Our Sites
Participants Sought for Clinical Trial to Test Vamorolone in DMD - Muscular Dystrophy Association
About the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN)
FDA Approves Vyondys 53 for Duchenne Muscular Dystrophy - MPR
CRISPR technologies for the treatment of Duchenne muscular dystrophy: Molecular Therapy
Cells | Free Full-Text | Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials
DMD: gene therapy clinical trial starting in France - Institut de Myologie
In reversal, FDA approves Duchenne muscular dystrophy drug
